Taysha Gene Therapies, Inc. (TSHA) is currently at $2.26, up $0.64 or 38.96%
--Would be highest close since Sept. 13, 2024, when it closed at $2.29
--On pace for largest percent increase since Aug. 29, 2023, when it rose 42.02%
--Currently up five consecutive days; up 78.35% over this period
--Longest winning streak since Feb. 22, 2024, when it rose for five straight trading days
--Best five day stretch since the five days ending Aug. 18, 2023, when it rose 159.81%
--Up 34.02% month-to-date
--Up 27.97% year-to-date; on pace for best year on record (Based on available data back to Sept. 24, 2020)
--Down 92.87% from its all-time closing high of $31.75 on Jan. 20, 2021
--Up 70.3% from 52 weeks ago (Nov. 14, 2023), when it closed at $1.33
--Down 45.68% from its 52-week closing high of $4.17 on June 13, 2024
--Up 78.35% from its 52-week closing low of $1.27 on Nov. 5, 2024
--Traded as high as $2.30; highest intraday level since Sept. 16, 2024, when it hit $2.31
--Up 41.1% at today's intraday high; largest intraday percent increase since March 20, 2024, when it rose as much as 41.16%
All data as of 1:48:42 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 12, 2024 13:53 ET (18:53 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments